<DOC>
	<DOCNO>NCT00343889</DOCNO>
	<brief_summary>The purpose study support registration pentavalent DTaP-HB-PRP~T vaccine country follow World Health Organization-Expanded Program Immunization ( WHO-EPI ) schedule . The primary objective : - To demonstrate pentavalent DTaP-HB-PRP~T combine vaccine induce low immune response Tritanrix-HepB/Hib™ term seroprotection rate hepatitis B ( HB ) one month 3-dose primary series 6 , 10 , 14 week age . The secondary objective : - To describe group immunogenicity parameter one month 3-dose primary series 6 , 10 , 14 week age ; - To evaluate overall safety term adverse event first 28 day injection serious adverse event entire trial .</brief_summary>
	<brief_title>Comparison DTaP-HB-PRP~T Combined Vaccine Tritanrix-HepB/Hib™ , Both Given Concomitantly With Oral Polio Vaccine</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Tetanus</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Haemophilus Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Six week old infant ( 42 50 day old ) day inclusion ; either gender . Mother test seronegative hepatitis B surface antigen ( HBsAg ) 28 week pregnancy 4 day delivery Born full term pregnancy ( ≥ 37 week ) birth weight ≥ 2.5 kg Informed consent form sign one parent legal representative appropriate ( independent witness mandatory parent illiterate ) Able attend schedule visit comply trial procedure . Participation another clinical trial 4 week precede first trial vaccination Planned participation another clinical trial present trial period Congenital acquire immunodeficiency ; immunosuppressive therapy longterm systemic corticosteroid therapy . Chronic illness stage could interfere conduct completion trial Blood bloodderived product receive since birth HB vaccination since birth Any vaccination four week precede first trial vaccination Any plan vaccination ( except trial vaccine bacillus CalmetteGuerin ( BCG ) trial Documented history pertussis , tetanus ( T ) , diphtheria ( D ) , polio , Haemophilus influenzae type b ( Hib ) infection ( ) ( confirm either clinically , serologically , microbiologically ) Known personal maternal history HIV , HBsAg hepatitis C seropositivity Thrombocytopenia bleed disorder contraindicate intramuscular ( IM ) vaccination History seizure Febrile ( rectal temperature ≥ 38.0°C ) acute illness day inclusion .</criteria>
	<gender>All</gender>
	<minimum_age>42 Days</minimum_age>
	<maximum_age>50 Days</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Diphtheria</keyword>
	<keyword>Tetanus</keyword>
	<keyword>Pertussis</keyword>
	<keyword>Hepatitis B Hansenula ( HB )</keyword>
	<keyword>Haemophilus influenzae type b</keyword>
	<keyword>Haemophilus Influenzae</keyword>
</DOC>